The domestic pharmaceutical market is valued at about 50 billion dollars, while the APIs, bulk drugs and advanced intermediates segment alone was worth roughly 3.5 billion dollars in FY25 India to ...
NEW DELHI: Facing mounting scrutiny over drug safety lapses, India is preparing an overhaul of its pharmaceutical licensing framework by introducing a separate wholesale licensing regime for bulk ...
Bulk SMS marketing has been around for years, yet in 2025 it is still quietly outperforming many “new” digital channels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results